Clinical trial
HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT
NCT00380770 · University of KwaZulu, Other · Completed
Key facts
| NCT number | NCT00380770 |
|---|---|
| Title | HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT |
| Official title | A Prospective Randomized Trial Comparing the Response of HIV Kaposi's Sarcoma (KS) to HAART Versus the Combination of HAART and Chemotherapy (CXT) |
| Acronym | KAART |
| Lead sponsor | University of KwaZulu, Other |
| Collaborators | AIDS Care Research in Africa National Research Foundation, Singapore AIDS Malignancy Consortium Cipla Medpro Industry Dermatological Society of South Africa |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV, AIDS, Kaposi's Sarcoma, Human Herpesvirus 8 |
| Intervention type | Drug |
| Interventions | Generic HAART Triomune : d4T, 3TC, NVP, NVP and chemotherapy ABV |
| Enrollment | 112 |
| Start date | Jan 1, 2003 |
| Primary completion | Feb 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Sep 26, 2006 |
| Last update posted | Jul 21, 2010 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: